In a nutshell The authors aimed to determine the predicting value of the platelet to lymphocyte ratio (PLR) in prostate cancer patients treated with hormone therapy. The authors concluded that the PLR might play a significant role in the prognosis of prostate cancer patients treated with hormone therapy. Some background The PLR is based on the...
Read More
In a nutshell The authors aimed to determine the benefit of robot-assisted radical prostatectomy (RARP) compared to retro-pubic radical prostatectomy (RRP) in reducing biochemical recurrence in men with prostate cancer. The authors concluded that RARP compared to RRP improved positive surgical margins (PSM) and biochemical recurrence. Some...
Read MoreIn a nutshell The authors aimed to determine the long-term effects of different exercises on fatigue in men with prostate cancer who are receiving hormone therapy. The authors concluded that different exercises had different but comparable effects on reducing fatigue during hormone therapy. Some background Hormone therapy is a common treatment...
Read More
In a nutshell This review outlined the opinions of the American Society of Clinical Oncology for the treatment of hormone therapy resistant men with prostate cancer. Some background Advanced prostate cancer is cancer that has spread outside the prostate gland into surrounding organs. In some cases, cancer can become hormone-resistant. This is when...
Read More
You may not know this but you can get warnings from the FDA on problems with prescription medications and over-the-counter drugs. For example, on August 11, a FDA News Release issued this warning about over-the-counter liquid vitamins that are given to young children and those who cannot swallow pills. “The U.S. Food and Drug Administration is...
Read More
In a nutshell The authors aimed to determine the benefit of abiraterone acetate (Zytiga) plus prednisone (Deltasone) with hormone therapy in men with newly diagnosed, advanced prostate cancer. The authors concluded that adding abiraterone acetate plus prednisone to hormone therapy significantly increased overall survival and progression-free survival...
Read More
In a nutshell The authors aimed to determine the use of pre-treatment bone scan index (BSI) as a prognostic (predictive) factor in hormone-naïve men with prostate cancer who have bone tumors. The authors concluded that pre-treatment BSI and patients age were independent prognostic factors for men with hormone-naïve prostate cancer with bone...
Read MoreIn a nutshell The authors aimed to determine whether a high dairy intake could increase the risk of prostate cancer progression. The authors concluded that there was a positive connection between high-fat milk intake and prostate cancer progression in men with localized (confined to the prostate gland) prostate cancer. Some background High dairy...
Read More
In a nutshell The authors aimed to determine the changes in cognitive performance (CP) after 6 months of hormone therapy with luteinizing hormone-releasing hormone (LHRH) analogues. The authors concluded that CP in men with prostate cancer does not appear to be affected following 6 months of LHRH treatment. Some background Androgen...
Read More
This summer has been a challenge after a family member with celiac disease had a gluten exposure (Click here to read more about celiac disease). Gluten damages the small intestine villi (see 5 Facts You Probably Didn’t Know About Your Small Intestines), which are essential for nutrition absorption. For over a month, gastrointestinal pain, vomiting...
Read More
Last summer we provided a series of posts on oncology basics. Oncology Basics: Preparing for ASCO covered some of the history of oncology. In Understanding Cells, we reviewed what is newly understood about cells–it’s way beyond what you learned in high school biology. DNA with lots of animated videos also explained some of the basics...
Read More
In a nutshell The authors aimed to determine the effect of tumor-directed stereotactic body radiotherapy in prostate cancer patients with oligometastases. The authors concluded that tumor-directed stereotactic body radiotherapy was a useful treatment for both oligorecurrent and oligoprogressive castration-resistant prostate cancer. Some...
Read More
